Cryptococcal infection in haematologic malignancies and haematopoietic stem cell transplantation

Mycoses. 2020 Oct;63(10):1033-1046. doi: 10.1111/myc.13153. Epub 2020 Aug 23.

Abstract

This review summarises both the recent and relevant studies about cryptococcal infections in haematologic malignancies and haematopoietic stem cell transplantation. Although uncommon in this patient population, this infection carries a high mortality, especially if left untreated. Given the limited data, we draw some conclusions with respect to management from the solid organ transplantation and HIV-infected literature. Herein, we discuss cryptococcosis with a particular attention to its background, epidemiology, risk factors, clinical presentation, diagnosis, treatment and prevention in this group.

Keywords: Cryptococcus neoformans; Cryptococcosis; amphotericin B; fluconazole; immune reconstitution.

Publication types

  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / microbiology
  • Antifungal Agents / therapeutic use
  • Cryptococcosis* / diagnosis
  • Cryptococcosis* / drug therapy
  • Cryptococcosis* / epidemiology
  • Cryptococcosis* / pathology
  • Cryptococcus gattii / isolation & purification
  • Cryptococcus gattii / pathogenicity
  • Cryptococcus neoformans / isolation & purification
  • Cryptococcus neoformans / pathogenicity
  • HIV Infections / complications
  • Hematologic Neoplasms / complications*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Incidence
  • Meningitis, Cryptococcal / diagnosis
  • Meningitis, Cryptococcal / drug therapy
  • Meningitis, Cryptococcal / epidemiology
  • Meningitis, Cryptococcal / pathology
  • Mortality
  • Risk Factors
  • Virulence

Substances

  • Antifungal Agents